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Alcian Blue 8GX is a cationic dye that forms insoluble complexes with acid glycosaminoglycans under suitable conditions (Scott et al., 1964) .
In the preceding paper (Whiteman, 1973) a method was described for determining the Alcian Blue content of complexes formed from small quantities of glycosaminoglycan. The conditions required for maximum complex-formation with standard and urinary glycosaminoglycans were determined. The amount of complex formed was proportional to the amount of standard glycosaminoglycans in solution. A simple variation of the technique allowed a study of the critical electrolyte concentrations of glycosaminoglycans to be made.
The present report extends this method to the determination of the total glycosaminoglycan content of urine, a preliminary report of which has been given (Whiteman, 1972 School, London, and was prepared as described by Fletcher et al. (1970) .
Purified human serum albumin (fraction V) was supplied by Sigma (London) Chemical Co., Kingstonupon-Thames, Surrey, U.K., and yeast RNA and herring sperm DNA were from Koch-Light Laboratories Ltd., Colnbrook, Bucks., U.K.
All other reagents were A.R. grade. Urine, preserved with merthiolate, was obtained from control subjects (children) and from patients with Hurler's and Sanfilippo's syndromes.
Methods
Determination of total urinary glycosaminoglycans by using Alcian Blue 8GX. The basic method is described in detail in the preceding paper (Whiteman, 1973) . In the standard procedure, standard glycosaminoglycan solution (20,u containing 1-l10,g of glycosaminoglycan) or centrifuged urine (20,u for mucopolysaccharidosis patients; 50,ul for control subjects) was mixed with 1 ml of a reagent containing 0.05 % (w/v) Alcian Blue 8GX and 50mM-MgCl2 in 50mM-sodium acetate adjusted to pH5.8 with acetic acid. After equilibration for 2h at room temperature, the glycosaminoglycan-Alcian Blue complex was separated by centrifugation at 2000g for 15min. After the precipitate had been washed with ethanol (2m1) it was dissociated with 1 ml of 40% (w/v) Manoxol IB solution. The E620 of the resulting clear blue solution was measured in 1 cm microcuvettes and a Unicam SP. 500 spectrophotometer. The glycosaminoglycan contents of urine samples were determined by reference to a calibration curve constructed by using chondroitin 4-sulphate as standard. Although the results could be conveniently expressed as mg of glycosaminoglycan/litre of urine, they were converted into the equivalent uronic acid concentration for comparison with other methods; the sodium chondroitin 4-sulphate used in this study contained 34.1 % (w/w) of uronic acid.
Variations in the standard procedure are indicated in the appropriate sections.
Measurement of urinary glycosaminoglycan after the removal of Tamm-Horsfall glycoprotein. After equilibration with 0.5M-MgCl2 at pH4.8 for 1 h at room temperature, over 80% of purified TammHorsfall glycoprotein (50, ug) added to water (50,u1) or urine (50,ul) could be removed as a transparent gel by centrifugation at 2000g for 15min. Precipitation of the glycoprotein was monitored by measuring the corresponding reduction in material chromophilic for Alcian Blue in the supernatant. The following procedure was therefore adopted as a means of measuring urinary glycosaminoglycan after the removal of Tamm-Horsfall glycoprotein.
Urine (0.2ml) was mixed with 1 M-MgCl2 (0.2ml) and allowed to equilibrate at room temperature for 1 h. After centrifugation at 2000g for 15min, 0.1 ml of supernatant was mixed with water (0.1 ml) and 0.8ml of a reagent containing Alcian Blue and sodium acetate buffer at a concentration 1.25 times that used in the standard reagent. The resulting Alcian Blueglycosaminoglycan complex was then treated as in the standard procedure described above.
Determination of uronic acid. The Alcian Blueprecipitable uronic acid content of urine was determined by the method described in the preceding paper (Whiteman, 1973) , apart from adjustments to the sample and reagent volumes to allow for differences in glycosaminoglycan concentration. Chondroitin 4-sulphate was used as a reference standard.
Cetylpyridinium chloride-precipitable uronic acid was determined by the method of Manley & Hawksworth (1966) , including an autoanalyser modification of the carbazole reaction of Bitter & Muir (1962) .
Characterization of urinary glycosaminoglycans by electrophoresis. Urine (1-2ml) was mixed with lOvol. of Alcian Blue reagent containing 50mM-MgCl2 and equilibrated for 2h at room temperature. After centrifugation, the complex was dissociated by vigorous shaking with 60,u of 4M-NaCl-methanol (2:1, v/v). Free Alcian Blue was precipitated by the addition of0.1 M-Na2CO3 (20,u1) (J. E. Scott, personal communication) and water (60,u1 ). Narrow bands of 1-2,u1 of urinary glycosaminoglycan or reference standard glycosaminoglycan solutions (1 mg/ml) were applied.
Electrophoresis proceeded for 3h in O.1M-barium acetate with an applied potential gradient of 7.5 V/cm. Strips were stained for 1 h with 0.05 % (w/v) Alcian Blue containing 50mM-MgCl2 in 50mM-sodium acetate buffer (pH 5.8) and washed with a solution of 50mM-MgCl2 in 50mM-sodium acetate buffer (pH 5.8). Clear-blue bands on a white background were obtained.
Results
Interaction of Alcian Blue and urinary glycosaminoglycans
The effect of MgCl2 concentrations on the formation ofinsoluble complexes between Alcian Blue 8GX and glycosaminoglycans in the urine of two patients with mucopolysaccharidosis is illustrated in Fig. 1 . Maximum complex-formation occurred in the presence of 50mM-MgCl2 both before and after dialysis (Fig. 1 ) appeared to be consistent with the known molecular-weight distributions of urinary glycosaminoglycans in these patients. Constantopoulos (1968) , using gel filtration, showed that patients with Sanfilippo's syndrome excreted heparan sulphate with an average molecular weight of 2300, whereas the urine ofpatients with Hurler's syndrome exhibited a dermatan sulphate fraction of molecular weight approx. 9000 and a larger fraction containing both heparan sulphate and dermatan sulphate with an average molecular weight of 2300. The very low critical electrolyte concentration of most of the glycosaminoglycan excreted in our patient with Sanfilippo's syndrome and the more extended critical electrolyte concentration pattern found in our patient with Hurler's syndrome correlate well with the findings of Constantopoulos (1968) .
Further evidence was provided by electrophoresis of a concentrate of urine from the patient with Sanfilippo's syndrome. Two bands were detected when strips were stained with Alcian Blue at different concentrations of MgCl2. One band corresponded to heparan sulphate with a critical electrolyte concentration between 0.1 and 0.2M-MgCl2 and the other to chondroitin sulphate with a critical electrolyte concentration of 0.3-0.4M-MgCl2. The critical electrolyte concentration of chondroitin sulphate is also indicated by the small inflexion between 0.3 and 0.4M-MgCl2, shown in Fig. 1 . Comparison of the reaction profiles for urine before and after dialysis shows a proportionately greater loss of material of low critical electrolyte concentration, which would be expected if the main factor causing differences in the critical electrolyte concentrations of polyanions in these specimens was a difference in the molecularweight distribution of glycosaminoglycans. These findings suggest that the Alcian Blue method may provide useful information on the nature of the polyanions, in addition to its proposed use for the quantitative analysis of glycosaminoglycans (Whiteman, 1972) . The method can be compared with the fractionation of cetylpyridinium chloride-glycosaminoglycan complexes in salt solutions, except that the amount of complex remaining is measured rather than the amount of glycosaminoglycan eluted from the complex. According to Scott (1970) When polyanions in the urine of patients with Hurler's and Sanfilippo's syndromes were equilibrated with Alcian Blue, maximum complexformation occurred well within the 2h equilibration period of the standard procedure (Fig. 2) . It appeared therefore that maximum interaction ofurinary glycosaminoglycans with Alcian Blue occurred in the presence of 50mM-MgCl2 (pH5.8) and could be measured by using the standard procedure previously described (Whiteman, 1973) .
Effect of urine sample volume on complex-formation:
When varying amounts of undialysed urine (from a normal infant), up to a total of 100ul, were equilibrated with 1 ml ofAlcian Blue reagent, proportionate increases in the amount of Alcian Blue-glycosaminoglycan complex formed were observed (Fig. 3) . After dialysis, urine additions also produced a linear response but gave very slightly lower values (after allowing for volume changes). The apparent loss of a small amount of polyanion during dialysis was less than Time of equilibration (h) (Fig. 4) .
Interaction ofserum andplasmapolyanions with Alcian
Blue Table 2 . Maximum interaction occurred in the presence of 50mM-MgCl2 and the critical electrolyte concentration pattern resembled that obtained with polycarboxylates. This polyanionic effect is presumably due at least partly to the presence of sialic acid, although Fletcher et al. (1970) found only 4.4 % (w/w) of sialic acid in TammHorsfall glycoprotein. Colour development (E620) in the standard procedure with 50mM-MgCl2 was about one-fifth of that obtained by using the same weight of chondroitin 4-sulphate. The low concentration of Tamm-Horsfall glycoprotein present in normal subject's urine and its relatively low uptake of Alcian Blue make it unlikely that its presence contributes significantly to the values ascribed to total urinary glycosaminoglycans by using the present method. However, a method of removing Tamm-Horsfall glycoprotein before the addition of Alcian Blue is described in the Experimental section. It likely that these substances would appear in centrifuged urine in concentrations sufficient to alter values ascribed to glycosaminoglycans, measured by using the Alcian Blue method. The results described in Table 4 show that uronic acids and hexose 6-sulphates do not react with Alcian Blue under standard conditions. Many other substances apart from those in Table 4 were investigated, including other amino acids, carboxylic acids, bile salts and acids and steroid conjugates; none formed complexes with Alcian Blue by using the standard procedure. Table 3 . There was good correlation between the three methods despite differences in the concentration of the urine specimens (as measured by the urinary creatinine concentration) and in the type of glycosaminoglycan present.
A series of duplicate determinations on ten urine samples gave an average coefficient of variation of ±2.7%.
General Discussion
A simple highly reproducible micro method for the determination of total urinary glycosaminoglycans has been described. It has several advantages over other methods. Apart from the initial centrifugation of a small quantity of urine no further preparation of the sample is required. The whole procedure can be carried out in a small disposable plastic tube, no heating is required and the reagents used are neither noxious nor dangerous. Although a 2h period of equilibration and two 15min periods ofcentrifugation are advised, the actual time involved in manipulative procedures is about 15min and large numbers of samples can be analysed in one batch, a feat difficult to achieve by using the carbazole reaction for uronic acids.
1973
The Alcian Blue technique measures glycosaminoglycans by virtue of their polyanionic nature rather than the constituent groups in the backbone chain. In this respect it provides a new parameter of glycosaminoglycan analysis and may be a useful complement to other methods. No single chemical determination is entirely satisfactory, owing to the variable constituents of different glycosaminoglycans. Uronic acid measurement by the modified carbazole reaction depends not only on the amount ofuronic acid present but also partly on the type of uronic acid. The keratan sulphates contain little or no uronic acid. The Alcian Blue method has been shown to be relatively specific under the conditions prescribed. The main theoretical objection to the method is the reaction given by nucleic acids, but in practice this is unlikely to be of importance in the measurement of urinary glycosaminoglycans. The reaction given by Tamm-Horsfall urinary glycoprotein with Alcian Blue is interesting and suggests that parts ofthe molecule present anionic charges in a manner comparable to the glycosaminoglycans. Apart from the method for the removal of Tamm-Horsfall glycoprotein described in the Experimental section of the present paper, it may be possible to remove both this glycoprotein and nucleic acids by using an ultrafiltration technique, since the molecular weights of these substances are much higher than are the molecular weights of urinary glycosaminoglycans.
A previous report (Whiteman, 1973) indicated how the Alcian Blue method described here may also be used to obtain qualitative information about standard glycosaminoglycans in solution by a study of critical electrolyte concentrations. The reaction profiles of urinary glycosaminoglycans in patients with mucopolysaccharidosis correlate well with the known molecular-weight distributions of these substances in the urine of such patients. The method may also be extended on a larger scale to allow fractionation of glycosaminoglycans, thus obviating the use of ion-exchange columns. An example of how glycosaminoglycans may be isolated by using this system was indicated in the Experimental section in the preparation of urinary glycosaminoglycans for electrophoresis.
